Shoe Modification and Knee Osteoarthritis
1 other identifier
interventional
40
1 country
1
Brief Summary
This trial will assess the ability of shoe inserts to relieve pain and disability in people with knee osteoarthritis (OA) in the inner (medial) aspect of the knee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable knee-osteoarthritis
Started Mar 2004
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2004
CompletedFirst Submitted
Initial submission to the registry
March 11, 2005
CompletedFirst Posted
Study publicly available on registry
March 14, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedOctober 21, 2015
October 1, 2015
1.5 years
March 11, 2005
October 20, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
WOMAC pain scale
6 months
Study Arms (2)
walking shoes
PLACEBO COMPARATORwalking shoes
walking shoes + shoe insert
EXPERIMENTALwalking shoes + shoe insert
Interventions
Subjects with knee OA underwent gait analysis and knee pain and function assessment at baseline while wearing walking shoes and after four weeks of wearing walking shoes with lateral-wedged insoles.
Eligibility Criteria
You may qualify if:
- Ability to walk 30 feet without a walking aid
- Ability to stand unaided
- Ability to understand verbal instructions
- Ability to give informed consent
You may not qualify if:
- History of knee trauma or surgery including arthroscopic surgery in the past 6 months
- Severe obesity (\>30 kg/m2)
- Neurological disease
- Injury or amputation to the lower extremity joints
- History of other types of arthritis
- Symptomatic spine, hip, ankle, or foot disease that would interfere with assessment of the knee
- Intra-articular steroids in the past 3 months, or hyaluronic acid in the last 6 months
- Poor health that would impair compliance or assessment such as shortness of breath with exertion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California, 90073, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Meika A Fang, MD
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2005
First Posted
March 14, 2005
Study Start
March 1, 2004
Primary Completion
September 1, 2005
Study Completion
September 1, 2005
Last Updated
October 21, 2015
Record last verified: 2015-10